Opinion · 30 Nov 2024
Conference abstractPublished 13 Jun 2018
Perspective on neurobiological and clinical early indicators of mild cognitive decline and alzheimer′s disease
American University in Dubai, UAE
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
There is a need for early diagnosis, monitoring and treatment of AlzheimerâÂ?Â?s Disease (AD) and Mild Cognitive Impairment (MCI). Traditional assessments of cognitive decline have been found to lack sensitivity and accuracy in differentiating varying stages of Dementia and cognitive decline as well as being time consuming in their administration. Key components of cognition namely memory and executive function have been identified as most predicative of AD status. Brief cognitive screening tools such as the Montreal cognitive assessment have been recommended both as a primary clinical and research assessment offering more sensitivity in differentiating AD and MCI. However, overlapping clinical features and impairments in cognitive processing suggest a need for biological risk factors. Neurobiological indicators of cognitive deterioration have been identified implicating measures of cerebrospinal fluid and temporal lobe atrophy as potential biomarkers of early clinical phases of AD and predictors of cognitive decline. Evidence shows the utility of automated classification methods in processing and analyzing multivariate neuroimaging data which improves our accuracy for the prediction of conversion of MCI to AD. In this review, we discuss the clinical usefulness of such approaches and the need for big data and multi-site studies in improving our understanding of AD neuropathology and confirming pathophysiological mechanisms that can reliably be used to differentiate MCI and AD and predict disease progression and cognitive decline.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 29 Jul 2024
Stages of Mild Cognitive Impairment and Alzheimer?s Disease can be Differentiated by Declines in Timed Up and Go Test: A Systematic Review and Meta-Analysis
Short communication · 30 Nov 2024
Understanding Alzheimer's Disease: Early Detection, Cognitive Decline, and Memory Loss Mechanisms
Research article · 2013
A New Scale for the Evaluation of Proactive and Retroactive Interference in Mild Cognitive Impairment and Early Alzheimer’s Disease
Conference abstract · 2012
Cognitive Biomarkers: SAGE screening for the early identification of mild cognitive impairment and Alzheimer’s disease
More from this journal
The newest in Journal of Alzheimers Disease & Parkinsonism.
Commentary · 8 Jun 2026
Cognitive Concerns: The Side Effects of Surgery in Alzheimer's Patients
Perspective · 8 Jun 2026
Oxidative Stress and Its Role in Neuronal Degeneration: Mechanisms and Implications
Commentary · 8 Jun 2026
Understanding the Pathophysiology of Prion-Induced Dementia
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Alzheimers Disease & Parkinsonism
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Jigar Jogia”
